University of California San Francisco
Novel Gene Therapy Trial for Sickle Cell Disease Launches
UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease. The trial is the first in the U.S. to apply non-viral CRISPR-Cas9 gene-editing technology in humans to directly correct the genetic mutation that causes the disease.
Chancellor Celebrates UCSF’s ‘Momentum’ in 2024 State of the University Address
Defined as the product of mass and velocity, “momentum” is derived from physics. It also describes UC San Francisco’s journey in the past decade under Chancellor Sam Hawgood’s leadership.
UCSF Joins I-Corps’ New Regional Innovation Hub for the Northwest
UC San Francisco is part of a new Northwest Region Innovation Corps (I-Corps) Hub funded by the National Science Foundation to train faculty and student entrepreneurs on how to commercialize their research.
The Hub, which will receive up to $15 million over five-years, will be led by UC Berkeley and includes UC Davis, UC Irvine, UC Santa Cruz, Oregon State University, University of Alaska Fairbanks and the University of Washington.
48 UCSF Researchers Are Honored for Their High-Impact Science
Nearly 50 UCSF researchers have been named to Clarivate’s list of most influential scientists for 2024.
How Optogenetics Can Put the Brakes on Epilepsy Seizures
A technique involving the use of light pulses to prevent seizure-like activity in neurons could one day become a new, non-invasive treatment for epilepsy.
New Study Looks at Why Cancer Treatments Cause Heart Damage
New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new discipline in medicine, called cardio-oncology.
Why This Gender Nonbinary UCSF Staffer Offers ‘Grace’ for Simply Trying
The GRLN policy empowers individuals like Jae Rouse, promoting inclusivity and impacting personal lives.
Engineered Receptors Help the Immune System Home in on Cancer
UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer therapies with minimal side effects.